Maria Sharapova lifts Wimbledon woes after being accepted into Harvard Business School
Russian is appealing a two-year ban after she tested positive for meldonium but is already preparing for a life after tennis
MARIA SHARAPOVA has put her Wimbledon woe behind her after enrolling for a course at the prestigious Harvard Business School.
The Russian ace is serving a two-year doping ban, which she is appealing, after testing positive for meldonium during January's Australian Open.
And despite the ex-champ missing the SW19 Grand Slam, Sharapova is putting her time to good use.
She shared pictures of herself on the Ivy League campus, posing for snaps and looking over notes.
The Harvard Business School accepted only 11 per cent of all 2016 applicants.
Meldonium was added to the list of banned substances at the start of 2016.
And after her positive test, Porsche and TAG Heuer cancelled their deals with Sharapova, while the United Nations also her status as a goodwill ambassador.
The athlete's ban lasts until January 25, 2018, but Sharapova has launched an appeal to the Court of Arbitration for Sport (CAS).
She insists she has taken the heart medication since 2006 and was unaware it had been added to the World Anti-Doping Agency (WADA) banned list.
CAS is expected to deliver its ruling by July 18, with reports suggesting it could spell the end of Sharapova's career.
But even if the ban is upheld, the Russian appears to be well on her way to preparing for a life after tennis.